364385-54-6

Basic information

• Product Name: Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI);Cis-(1R, 2S)-1N-Boc-cyclohexane-1,2-diamine;tert-butyl (1R,2S)-2-aminocyclohexylcarbamate;N-Boc-1(R),2(S)-diaminocyclohexane;tert-Butyl N-[(1R,2S)-2-aminocyclohexyl]carbamate;(1R,2S)-Cyclohexane-1,2-diamine, 1-BOC protected;tert-Butyl [(1R,2S)-2-aminocyclohex-1-yl]carbamate, (1R,2S)-1,2-diaminocyclohexane, N1-BOC protected;(1R,2S)-N1-(tert-Butoxycarbonyl)-1,2-cyclohexanediaMine
• CAS NO: 364385-54-6
• Molecular Formula: C₁₁H₂₂N₂O₂
• Molecular Weight: 214.30458
• Product Categories: N-BOC
• Mol File: 364385-54-6.mol
• Article Data: 7

Chemical Properties

• Melting Point: 181-183 °C
• Boiling Point: 322.1±31.0 °C(Predicted)
• Appearance: /
• Density: 1.02±0.1 g/cm3(Predicted)
• Storage Temp.: 0-10°C
• Solubility: soluble in dichloromethane
• PKA: 12.26±0.40(Predicted)
• CAS DataBase Reference: Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI)(364385-54-6)
• EPA Substance Registry System: Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI)(364385-54-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 364385-54-6(Hazardous Substances Data)

Usage

General Description

Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI) is a chemical compound with the molecular formula C11H21NO2. It is an ester derivative of carbamic acid and is commonly used as a pharmaceutical intermediate in the synthesis of various drugs. Carbamic acid, [(1R,2S)-2-aminocyclohexyl]-, 1,1-dimethylethyl ester (9CI) is characterized by its 1,1-dimethylethyl ester group attached to the cyclohexylamine moiety. It is used in the preparation of pharmaceuticals and related compounds, and also has potential applications in chemical research and development. Additionally, it may have important biological and medicinal properties that make it a subject of interest for further study in the fields of pharmacology and medicinal chemistry. Please note that this is a general summary and should not be considered as professional advice. Any specific use of this compound should be conducted under the guidance of a qualified professional.

Upstream product

• 603128-65-0 (1S,2R)-2-(N-tert-butyloxycarbonylamino)-1-azidocyclohexane 
• 110716-78-4 (1R,2R)-trans-2-azidocyclohexanol 
• 286-20-4 cyclohexane-1,2-epoxide 
• 155975-19-2 (1R,2R)-trans-2-(N-tert-butyloxycarbonyl)amino-1-cyclohexanol 
• 603128-64-9 (1R,2R)-2-(N-tert-butoxycarbonylamino)-cyclohexan-1-yl methanesulfonate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 119479-49-1 (1S,2S)-trans-2-azidocyclohexanol 
• 115586-44-2 Butyric acid (1S,2S)-2-azido-cyclohexyl ester 
• 260065-86-9 (1R,2S)-2-amino-1-cyclohexanol 
• 364385-60-4 tert-butyl [(1R,2S)-2-(phthalimido)cyclohexyl]-carbamate 
• 694-83-7 rac-diaminocyclohexane 
• 1436-59-5 cis-cyclohexane-1,2-diamine 

Downstream Products

• 603128-66-1 N-[(2R)-tert-butyloxycarbonylaminocyclohex-(1S)-yl]glycine ethyl ester 
• 959976-64-8 4-((1S,2R)-2-tert-butoxycarbonylamino-cyclohexylamino)-piperidine-1-carboxylic acid benzyl ester 
• 603128-68-3 N-[(2R)-tert-butyloxycarbonylaminocyclohex-(1S)-yl]-N-(chloroacetyl)glycine ethyl ester 
• 603128-70-7 N-[(2R)-tert-butyloxycarbonylaminocyclohex-(1S)-yl]-N-(thymin-1-ylacetyl)glycine ethyl ester 
• 620957-77-9 tert-butyl ((1R,2S)-2-[(2-chloro-6-methylquinazolin-4-yl)amino]cyclohexyl)carbamate 
• 620957-84-8 ethyl 4-({(1S,2R)-2-[(tert-butoxycarbonyl)amino]cyclohexyl}amino)-6-methylquinazolin-2-carboxylate 
• 364386-47-0 (1R,2S)-N-tert-butoxycarbonyl-2-(2-chloro-6-methoxyquinazolin-4-yl)aminocyclohexylamine 
• 603128-65-0 (1S,2R)-2-(N-tert-butyloxycarbonylamino)-1-azidocyclohexane 
• 365996-30-1 tert-butyl ((1S,2R)-2-aminocyclohexyl)carbamate 
• 1370261-98-5 4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-((1R, 2S)-2-aminocyclohexylamino)pyrimidine-5-carboxamide acetic acid salt 

Relevant articles and documents

CYCLOHEXANEDIAMINE COMPOUNDS AND METHODS FOR THEIR PREPARATION

The present invention provides processes for the preparation of cyclohexanediamine compounds of formula Ia and intermediates thereof. The compounds are useful as Syk kinase inhibitors and in various pharmaceutical compositions, and particularly useful for treating conditions mediated at least in part by Syk kinase activity.

Novel Compounds

Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein A1, A2, G1, G2 G3, R1, R2, X, Y, Z, m, n and p are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

ETHYLENEDIAMINE DERIVATIVES

The invention relates a compound represented by the formula (1):Q1-Q2-C(=O)-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 represent H or the like; Q1 represents an aromatic ring, heterocyclic ring or the like; Q2 represents a single bond, aromatic ring, heterocyclic ring or the like; Q3 represents a group or the like, Q4 represents an aromatic ring, heterocyclic ring or the like; and T1 represents -CO- or -SO2-, and a medicine which comprises the compound and is useful for thrombosis and embolism.